|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.38 CNY | -3.45% |
|
+9.23% | +2.06% |
| 07-14 | Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-16 | Tasly Subsidiary Gets China Approval for Hypertension Drug | MT |
| Market Cap | 22.98B 3.39B 2.96B 2.73B 2.52B 4.75B 326B 4.85B 32.67B 12.85B 160B 12.73B 12.45B 550B | P/E 2026 * |
17.1x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 21.72B 3.2B 2.8B 2.58B 2.38B 4.49B 309B 4.59B 30.88B 12.15B 151B 12.03B 11.77B 520B | EV / Sales 2026 * |
2.41x | EV / Sales 2027 * | 1.76x |
| Free-Float |
47.15% | Yield 2026 * |
2.93% | Yield 2027 * | 3.34% |
| 1 day | -3.45% | ||
| 1 week | +9.23% | ||
| Current month | +16.25% | ||
| 1 month | +9.16% | ||
| 3 months | +7.93% | ||
| 6 months | +2.19% | ||
| Current year | +2.06% |
| 1 week | 14.11 |  | 16 |
| 1 month | 12.9 | | 16 |
| Current year | 12.9 | | 16 |
| 1 year | 12.9 | | 17.69 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 08/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 09/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 01/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiao Meng Jiang
BRD | Director/Board Member | 62 | 17/08/2007 |
Ai Jian Wang
BRD | Director/Board Member | 72 | 02/06/2021 |
Jin Yong Cai
BRD | Director/Board Member | 54 | 25/03/2006 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.45% | +9.23% | -5.06% | +7.03% | 3.39B | |
| -1.32% | +5.33% | -8.55% | -5.18% | 13.54B | |
| -3.30% | +9.97% | -27.67% | -49.81% | 5.27B | |
| -2.47% | +7.14% | +0.62% | -4.09% | 4.72B | |
| -5.06% | +6.38% | +8.55% | -32.43% | 4.07B | |
| -2.65% | +2.32% | +4.01% | -8.76% | 3.75B | |
| 0.00% | +9.56% | -4.89% | -3.35% | 3.57B | |
| -3.77% | +0.45% | -13.12% | -22.74% | 2.42B | |
| -2.82% | +3.13% | -1.88% | +49.73% | 1.86B | |
| -4.32% | +4.89% | -8.49% | -10.97% | 1.76B | |
| Average | -2.92% | +2.45% | -5.65% | -8.06% | 4.43B | |
| Weighted average by Cap. | -2.51% | +3.01% | -6.62% | -10.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9B 1.33B 1.16B 1.07B 987M 1.86B 128B 1.9B 12.79B 5.03B 62.61B 4.99B 4.88B 216B | 9.78B 1.44B 1.26B 1.16B 1.07B 2.02B 139B 2.07B 13.91B 5.47B 68.08B 5.42B 5.3B 234B |
| Net income | 1.36B 201M 176M 162M 149M 281M 19.34B 288M 1.94B 761M 9.47B 754M 738M 32.61B | 1.61B 237M 207M 191M 176M 332M 22.85B 340M 2.29B 899M 11.19B 891M 871M 38.52B |
| Net Debt | -1.26B -186M -162M -150M -138M -260M -17.89B -266M -1.79B -704M -8.76B -697M -682M -30.15B | -5.78B -852M -745M -687M -633M -1.19B -82.07B -1.22B -8.21B -3.23B -40.2B -3.2B -3.13B -138B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | CN¥15.38 | -3.45% | 39,349,508 |
| 16/07/26 | CN¥15.93 | +4.19% | 51,417,352 |
| 15/07/26 | CN¥15.29 | +4.80% | 33,298,760 |
| 14/07/26 | CN¥14.59 | +1.46% | 20,381,548 |
| 13/07/26 | CN¥14.38 | +2.13% | 21,133,055 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
